EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Engineering Folic Acid‐Modified Nanoparticles to Enhance Letrozole's Anticancer Action

Neda Rostami, Abuzar Nikzad, Shervin Shaybani, Hadi Noei, Aida Ghebleh, Mehdi Alidadi, Hanie Abbasi, Sidi A Bencherif iD

Macromolecular Bioscience · 2025-07 · 25 (7)

DOI: 10.1002/mabi.202400558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Macromolecular Bioscience, online erschienen am 18.04.2025. Verfasst von Neda Rostami und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering, Arak University, Arak, 3848177584, Iran. Hauptthemen laut MEDLINE: Folic Acid, Letrozole, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, NIH HHS, "Chaire d'Excellence de Normandie".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of biodegradable nanoparticles (NPs) for delivering anticancer drugs, such as letrozole (LTZ), offers a targeted approach for cancer therapy. In this study, we synthesized poly(ε‐caprolactone)‐ co ‐poly(ethylene glycol) (PCL‐ co ‐PEG) and fabricated LTZ‐loaded PCL‐ co ‐PEG NPs (LTZ‐NPs) via emulsion‐solvent evaporation. Folic acid (FA), a folate receptor‐targeting molecule, was conjugated to the LTZ‐loaded NPs (LTZ‐FNPs) to enhance treatment efficacy against hormone receptor‐positive breast cancer cells. Both NPs and FNPs exhibited a spherical morphology (60–90 nm), with FNPs showing higher drug entrapment efficiency and controlled release. LTZ release was minimal at physiological pH but increased in acidic, cancer‐like environments, following the Korsmeyer‐Peppas model, indicating a combination of Fickian and non‐Fickian diffusion. In cytotoxicity assays, LTZ‐FNPs exhibited higher toxicity against MCF‐7 cells than LTZ‐NPs. Controlled LTZ release altered gene expression, reducing B‐cell leukemia/lymphoma 2 protein (Bcl2) and increasing caspase 8 (Casp8), promoting apoptosis. A shift to the SubG1 phase further confirmed enhanced LTZ‐FNP‐mediated cell death. Furthermore, p53 expression increased, while matrix metalloproteinase 9 (MMP‐9) decreased, inhibiting cell invasion. This study introduces a biodegradable system with FA‐functionalized, pH‐sensitive NPs for the targeted and controlled delivery of LTZ. This approach holds great potential for selective, efficient treatment while minimizing systemic toxicity in breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidLetrozoleNanoparticlesAntineoplastic AgentsBreast NeoplasmsTriazolesHumansMCF-7 CellsFemalePolyestersPolyethylene GlycolsApoptosisDrug Liberation

Stichwörter der Autor:innen

breast cancerscontrolled drug releaseletrozolepolymeric nanoparticlestargeted delivery

Substanzen

Folic AcidLetrozoleAntineoplastic AgentsPolyestersPolyethylene GlycolspolycaprolactoneTriazoles

Autor:innen und Institutionen

  • Department of Chemical Engineering, Arak University, Arak, 3848177584, Iran.
  • Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, 08854, USA.
  • Department of Chemistry, Wake Forest University, Winston-Salem, NC, 27101, USA.
  • Department of Medical Biology and Genetics, Faculty of Medicine, Istinye University, Istanbul, 34010, Turkey.
  • School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, 8174673461, Iran.
  • Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, 1461884513, Iran.

ORCID-Profile: Sidi A Bencherif

Förderung

  • NIBIB NIH HHS
  • NIH HHS
  • "Chaire d'Excellence de Normandie"
  • National Institutes of Health

Zitieren

APA

Rostami, N., Nikzad, A., Shaybani, S., Noei, H., Ghebleh, A., Alidadi, M., Abbasi, H., & Bencherif, S. A. (2025). Engineering Folic Acid‐Modified Nanoparticles to Enhance Letrozole's Anticancer Action. Macromolecular Bioscience, 25(7). https://doi.org/10.1002/mabi.202400558

Vancouver

Rostami N, Nikzad A, Shaybani S, Noei H, Ghebleh A, Alidadi M, et al. Engineering Folic Acid‐Modified Nanoparticles to Enhance Letrozole's Anticancer Action. Macromolecular Bioscience. 2025;25(7). doi:10.1002/mabi.202400558

BibTeX
@article{Rostami2025,
  author = {Rostami, Neda and Nikzad, Abuzar and Shaybani, Shervin and Noei, Hadi and Ghebleh, Aida and Alidadi, Mehdi and Abbasi, Hanie and Bencherif, Sidi A},
  title = {Engineering Folic Acid‐Modified Nanoparticles to Enhance Letrozole's Anticancer Action},
  journal = {Macromolecular Bioscience},
  year = {2025},
  volume = {25},
  number = {7},
  doi = {10.1002/mabi.202400558}
}
Kostenlos starten →